Preclinical evaluation of [123I]R93274 as a SPECT radiotracer for imaging 5-HT2A receptors
✍ Scribed by Anissa Abi-Dargham; Yolanda Zea-Ponce; Dirk Terriere; Mohamed Al-Tikriti; Ronald M Baldwin; Paul Hoffer; Dennis Charney; Josée E Leysen; Marc Laruelle; John Mertens; Robert B Innis
- Book ID
- 119413633
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 301 KB
- Volume
- 321
- Category
- Article
- ISSN
- 0014-2999
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The high‐affinity muscarinic receptor antagonist (R,R) I‐QNB^(1)^ [(R)‐(‐)‐1‐Azabicyclo [2.2.2]oct‐3‐yl‐ (R) ‐ (+) ‐ α‐hydroxy‐α‐(4‐[^127^I]iodophenyl)‐α‐phenyl Acetate (6a)] has been labeled with iodine‐123 to give a suitable ligand for SPECT (Single photon emission computed tomography
## Abstract In order to image nAChR density __in vivo__ in humans, [5‐^123^I]‐iodo‐3‐[2(S)‐2‐azetidinylmethoxy]pyridine ([5‐^123^I]A85380) has been developed as a SPECT imaging tracer. This article outlines the radiochemical synthesis, __in vitro__ validation in human post‐mortem tissue and some in